Inhibition of chronic tissue transplant rejection
AssigneeGenzyme Corporation
InventorJohn M. Williams
Life of this patent
Estimating the term…
Abstract
Disclosed is a method of inhibiting acute and chronic tissue transplant rejection in a subject with a tissue transplant. The method comprises the step of administering to the subject an effective amount of a compound represented by Formula (I): 1 The values of the variables in Formula (I) are described herein.
Claims26
A method of inhibiting tissue transplant rejection in a subject with a tissue transplant, said method comprising the step of administering an effective amount of a compound represented by Formula (I):
- 6
- or a physiological salt thereof, wherein:
- R1 is a substituted or unsubstituted aryl group or a substituted or unsubstituted alkyl group;
- R2 is an optionally substituted aralkyl group or an alkyl group substituted with —NR5R6;
- R3 is a substituted or unsubstituted alkyl group or a substituted or unsubstituted aryl group;
- R4 a substituted or unsubstituted alkyl group or a substituted or unsubstituted aryl group;
- and
- R5 and R6 are independently selected from a substituted or unsubstituted alkyl group or a substituted or unsubstituted aryl group or R5 and R6 taken together with the nitrogen to which they are attached are a non-aromatic heterocyclic group.
A method of inhibiting chronic tissue transplant rejection in a subject with a tissue transplant, said method comprising the step of administering an effective amount of a compound represented by Formula (I):
- 7
- or a physiological salt thereof, wherein:
- R1 is a substituted or unsubstituted aryl group or a substituted or unsubstituted alkyl group;
- R2 is an optionally substituted aralkyl group or an alkyl group substituted with —NR5R6;
- R3is a substituted or unsubstituted alkyl group or a substituted or unsubstituted aryl group;
- R4 a substituted or unsubstituted alkyl group or a substituted or unsubstituted aryl group;
- and
- R5 and R6 are independently selected from a substituted or unsubstituted alkyl group or a substituted or unsubstituted aryl group or R5 and R6 taken together with the nitrogen to which they are attached are a non-aromatic heterocyclic group.
A method of inhibiting tissue transplant rejection in a subject with a tissue transplant, said method comprising the step of administering an effective amount of a compound represented by the following structural formula:
- 10
- or a pharmaceutically acceptable salt thereof.
A method of inhibiting chronic tissue transplant rejection in a subject with a tissue transplant, said method comprising the step of administering an effective amount of a compound represented by the following structural formula:
- 11
- or a pharmaceutically acceptable salt thereof.
A method of inhibiting tissue transplant rejection in a subject with a tissue transplant, said method comprising the step of administering an effective amount of a compound represented by the following structural formula:
- 12
- or a physiologically acceptable salt thereof, wherein:
- R11 is —H, a substituted or unsubstituted aryl, a substituted or unsubstituted aralkyl, a substituted or unsubstituted heteroaryl or a substituted or unsubstituted heteroaralkyl;
- R12 is alkyl substituted with NR15R16, a substituted or unsubstituted aryl, a substituted or unsubstituted heteroaralkyl, or a substituted or unsubstituted heterocycloalkylalkyl;
- R13 is a substituted or unsubstituted alkyl, a substituted or unsubstituted aryl, a substituted or unsubstituted aralkyl, a substituted or unsubstituted cycloalkylalkyl, a substituted or unsubstituted heteroaryl, a substituted or unsubstituted heteroaralkyl, a substituted or unsubstituted benzophenonyl, or a substituted or unsubstituted cycloalkylalkyl;
- and
- each R14 is independently, —H, a substituted or unsubstituted alkyl, a substituted or unsubstituted aryl, substituted or unsubstituted aralkyl or a substituted or unsubstituted heteroaralkyl;
- R15 and R16 are independently selected from H, a substituted or unsubstituted alkyl, a substituted or unsubstituted cycloalkyl, a substituted or unsubstituted aryl or unsubstituted aralkyl or R13 and R14 together with the nitrogen to which they are attached are a heterocycloalkyl.
Dependencies are inferred from the claim text.